Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
JP Nadda inaugurates Jan Aushadhi Diwas celebrations
Under PMBJP, the government has set a target to open 25000 JAKs by March 31, 2027 across the country. The target of opening 15000…
EMA reiterates positive recommendation for Eisai-Biogen’s Alzheimer’s drug
The EMA's human medicines committee last year backed Leqembi for a narrower set of patients than those evaluated in a late-stage…
Glenmark USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose…
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and…
Tarunesh Madan highlights the evolving leadership landscape in Indian pharma, exploring emerging roles, global expansion…
Express Pharma March 2025
India's Foremost Pharma & Biotech Magazine ~ The Leadership Playbook: Tech, Talent, Transformation
Cardiol’s CRD-38 holds potential to differentiate in HF space: GlobalData
CRD-38’s alternative mechanism positions it as a potential new option in heart failure treatment
Sionna Therapeutics’ NBD1 stabilisers hold potential to differentiate from Vertex’s existing…
Sionna’s IPO signals investor interest amid competitive cystic fibrosis treatment landscape
Zydus launches India’s first flu vaccine for southern hemisphere 2025 strain
VaxiFlu-4 developed as per WHO-recommended composition for influenza protection
Lupin included in S&P Global Sustainability Yearbook 2025 for the second consecutive year
Lupin’s S&P Global CSA score has significantly improved from 65 to 75 in 2024
Glenmark announces launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial
The launch is eligible for 180 days of CGT exclusivity under the FD&C Act